Abstract

This is an Editorial and does not have an abstract.

Highlights

  • Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported for the first time in China in December 2019.[1]

  • The nasopharyngeal reverse transcription-polymerase chain reaction (RT-PCR) results were indicative of the presence of the virus in all patients with positive tear RT-PCR results, which comprised a case with clinical conjunctivitis.[11]

  • Many non-urgent ophthalmic services were ceased at the ophthalmology centers in Iran, similar to other countries, during the early months of the pandemic to tackle the spread of COVID19

Read more

Summary

Introduction

Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported for the first time in China in December 2019.[1]. A recently published meta-analysis reported that the risk of transmission is reduced by more than 75% through implementing three strategies by both healthcare workers and communities: at least a 1-m social distancing, use of a face masks (surgical or similar masks (12–16-layer cotton or gauze masks), N95 respirators or similar), and eye protection.[7] Recently, the WHO has released interim guidance on the use of masks for avoiding transmission of COVID19.[8]

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call